• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2006年美国甲状腺协会(ATA)的实践指南对美国分化型甲状腺癌的治疗产生影响了吗?

Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States?

作者信息

Goffredo Paolo, Roman Sanziana A, Sosa Julie A

机构信息

1 Department of Surgery, University of Milano-Bicocca , Monza, Italy .

出版信息

Thyroid. 2014 Mar;24(3):463-71. doi: 10.1089/thy.2013.0319. Epub 2013 Oct 29.

DOI:10.1089/thy.2013.0319
PMID:23978295
Abstract

BACKGROUND

There is wide variability in the degree of adherence to guideline recommendations among caregivers. Our aim was to determine the clinical impact of the 2006 guidelines from the American Thyroid Association (ATA) on the management of differentiated thyroid cancer (DTC) in the United States.

METHODS

The Surveillance, Epidemiology and End Results (SEER) database (2004-2009) was employed. Patients were divided into two groups based on receipt of care before (DTC 04-06) and after (DTC 07-09) the release of the 2006 ATA guidelines. Adherence was determined with a chi-square test and binary logistic regression. Survival was analyzed with the Kaplan-Meier method and log-rank test.

RESULTS

A total of 12,816 patients with DTC were identified between 2004 and 2006, and 14,514 between 2007 and 2009 (DTC 07-09). Adherence to Recommendation 26 (surgery) tended to increase in DTC 07-09 (82.2% vs. 83.2%, p=0.083). Factors associated with discordant practice among the DTC 07-09 group were older age, treatment in the Northeast, having more than one primary cancer, tumor size >4 cm, and follicular and Hürthle cell histologies. Factors associated with accordance were treatment in the Midwest, level II-VI metastases, having lymph nodes examined, AJCC Stage III, and presenting with distant metastases. Patients treated in accordance with Recommendation 26 showed prolonged disease-specific survival (p<0.001). A trend toward more adherence to Recommendation 27 (lymphadenectomy) was observed over time (68.4% vs. 69.7%, p=0.065). Adherence to Recommendation 27 was not associated with disease-specific survival (p=0.539). Less discordance from guidelines was seen for cancers that were 2.1-4 cm, extrathyroidal, and greater than Stage I. Overall accordance with Recommendation 32 (radioactive iodine [RAI] ablation) increased in DTC 07-09 compared to DTC 04-06 (61.7% vs. 57.5% respectively, p<0.001), and this was associated with improved disease-specific survival in DTC 07-09 (p<0.001). Predictors of care discordant with guidelines were patient age ≥ 65 years, living in the Northeast, and not undergoing total thyroidectomy. Factors associated with RAI use in accordance with guidelines were married status, treatment in the South, and having more than one lymph node examined.

CONCLUSIONS

Care in accordance with evidence-based guidelines for DTC is associated with improved patient outcomes. Ongoing efforts should be undertaken to propagate guidelines to reduce variation in care and improve overall quality of care.

摘要

背景

护理人员对指南建议的遵循程度存在很大差异。我们的目的是确定美国甲状腺协会(ATA)2006年指南对分化型甲状腺癌(DTC)管理的临床影响。

方法

采用监测、流行病学和最终结果(SEER)数据库(2004 - 2009年)。根据2006年ATA指南发布之前(DTC 04 - 06)和之后(DTC 07 - 09)接受治疗的情况将患者分为两组。通过卡方检验和二元逻辑回归确定遵循情况。采用Kaplan - Meier方法和对数秩检验分析生存率。

结果

2004年至2006年共识别出12816例DTC患者,2007年至2009年(DTC 07 - 09)有14514例。DTC 07 - 09组对建议26(手术)的遵循率有上升趋势(82.2%对83.2%,p = 0.083)。DTC 07 - 09组中与不一致做法相关的因素包括年龄较大、在东北部接受治疗、患有不止一种原发性癌症、肿瘤大小>4 cm以及滤泡性和许特莱细胞组织学类型。与一致做法相关的因素包括在中西部接受治疗、II - VI级转移、进行了淋巴结检查、美国癌症联合委员会(AJCC)III期以及出现远处转移。按照建议26接受治疗的患者疾病特异性生存期延长(p<0.001)。随着时间的推移,观察到对建议27(淋巴结清扫)的遵循有上升趋势(68.4%对69.7%,p = 0.065)。对建议27的遵循与疾病特异性生存期无关(p = 0.539)。对于2.1 - 4 cm、甲状腺外以及I期以上的癌症,与指南的不一致性较少。与DTC 04 - 06相比,DTC 07 - 09中对建议32(放射性碘[RAI]消融)的总体遵循率有所提高(分别为61.7%对57.5%,p<0.001),这与DTC 07 - 09中改善的疾病特异性生存期相关(p<0.001)。与指南护理不一致的预测因素为患者年龄≥65岁、居住在东北部以及未接受全甲状腺切除术。与按照指南使用RAI相关的因素包括婚姻状况、在南部接受治疗以及检查了不止一个淋巴结。

结论

按照DTC循证指南进行护理与改善患者预后相关。应持续努力传播指南,以减少护理差异并提高整体护理质量。

相似文献

1
Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States?2006年美国甲状腺协会(ATA)的实践指南对美国分化型甲状腺癌的治疗产生影响了吗?
Thyroid. 2014 Mar;24(3):463-71. doi: 10.1089/thy.2013.0319. Epub 2013 Oct 29.
2
Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?甲状腺髓样癌:美国的实践模式与美国甲状腺协会指南是否存在差异?
Ann Surg Oncol. 2010 Jun;17(6):1490-8. doi: 10.1245/s10434-010-1017-0. Epub 2010 Mar 12.
3
ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States?ATA 实践指南治疗分化型甲状腺癌:它们在美国得到遵循了吗?
Am J Surg. 2010 Feb;199(2):189-98. doi: 10.1016/j.amjsurg.2009.04.022.
4
Same thyroid cancer, different national practice guidelines: When discordant American Thyroid Association and National Comprehensive Cancer Network surgery recommendations are associated with compromised patient outcome.同样的甲状腺癌,不同的国家实践指南:当美国甲状腺协会和国家综合癌症网络不一致的手术建议与患者预后受损相关时。
Surgery. 2016 Jan;159(1):41-50. doi: 10.1016/j.surg.2015.04.056. Epub 2015 Oct 2.
5
T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?T1a 与 T1b 期分化型甲状腺癌:我们是否需要进行区分?
Thyroid. 2016 Aug;26(8):1046-52. doi: 10.1089/thy.2016.0073. Epub 2016 Jul 6.
6
Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades.分化型甲状腺癌伴远处转移:二十年的人群分析。
World J Surg. 2013 Jul;37(7):1599-605. doi: 10.1007/s00268-013-2006-9.
7
Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity.同时性髓样和分化型甲状腺癌:一种日益常见实体的人群水平分析。
Ann Surg Oncol. 2012 Aug;19(8):2635-42. doi: 10.1245/s10434-012-2357-8. Epub 2012 Apr 17.
8
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.基于证据的指南是否反映在临床实践中?意大利甲状腺癌观察站前瞻性收集数据的分析。
Thyroid. 2017 Dec;27(12):1490-1497. doi: 10.1089/thy.2017.0299. Epub 2017 Nov 10.
9
Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.使用循证指南可减少低风险分化型甲状腺癌患者的放射性碘治疗。
Thyroid. 2015 Apr;25(4):377-85. doi: 10.1089/thy.2014.0298. Epub 2015 Feb 6.
10
Postoperative radioactive iodine-131 ablation is not necessary among patients with intermediate-risk differentiated thyroid carcinoma: a population-based study.中等风险分化型甲状腺癌患者术后无需进行放射性碘-131消融治疗:一项基于人群的研究。
Hell J Nucl Med. 2017 Jan-Apr;20(1):3-10. doi: 10.1967/s002449910500. Epub 2017 Mar 20.

引用本文的文献

1
Choice of management strategy for papillary thyroid microcarcinoma: active surveillance or immediate surgery?甲状腺微小乳头状癌的管理策略选择:主动监测还是立即手术?
J Cancer. 2024 Jan 1;15(4):1009-1020. doi: 10.7150/jca.91612. eCollection 2024.
2
Improved Adherence to ATA Medullary Thyroid Cancer Treatment Guidelines.对美国甲状腺协会甲状腺髓样癌治疗指南依从性的提高
Ann Surg Oncol. 2023 Nov;30(12):7165-7171. doi: 10.1245/s10434-022-12734-3. Epub 2022 Nov 11.
3
Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer.
甲状腺癌流行病学及生存结局的全国性队列研究。
Oncotarget. 2017 Jul 22;8(45):78429-78451. doi: 10.18632/oncotarget.19488. eCollection 2017 Oct 3.
4
Thyroid cancer surgery guidelines in an era of de-escalation.甲状腺癌手术指南在降级时代。
Eur J Surg Oncol. 2018 Mar;44(3):297-306. doi: 10.1016/j.ejso.2017.03.005. Epub 2017 Mar 16.
5
National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.非晚期甲状腺髓样癌(MTC)手术治疗的全国趋势:对2009年美国甲状腺协会指南依从性的评估
World J Surg. 2016 Dec;40(12):2930-2940. doi: 10.1007/s00268-016-3643-6.
6
Trends in imaging after diagnosis of thyroid cancer.甲状腺癌诊断后的影像学发展趋势。
Cancer. 2015 May 1;121(9):1387-94. doi: 10.1002/cncr.29210. Epub 2015 Jan 6.